[对37例恶性间皮瘤的生存分析]
概括
早期开始治疗和组合疗法,特别是使用抗血管原体的化疗,可显著改善恶性间皮瘤患者的生存率. 只有息治疗就导致了更短的生存时间.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
- 医学瘤学 医学瘤学
背景情况:
- 恶性间皮瘤是一种罕见且具有攻击性的癌症,具有具有挑战性的诊断和治疗.
- 了解临床病理特征,治疗方法和患者预后之间的相互作用对于改善结果至关重要.
研究的目的:
- 研究诊断为恶性间皮瘤的患者临床病理学特征,治疗策略和生存率之间的关系.
- 为了确定预后因素,并评估不同治疗方法的疗效恶性间皮瘤.
主要方法:
- 从2014年7月至2022年11月期间诊断的37名恶性间皮瘤患者的临床数据的回顾性分析.
- 使用卡普兰-梅尔和日志等级测试来分析预后因素和生存数据.
主要成果:
- 所有患者的中位生存时间为30.00个月,五年生存率为13.51%.
- 化学疗法与贝瓦西祖马布向治疗相结合,平均存活时间为47.42个月,比其他疗法要长得多 (P<0.05).
- 临床病理学因素,如性别,年龄,吸烟史和疾病发生地没有显著影响生存率.
结论:
- 恶性间皮瘤具有非特异性临床症状,这强调了及时诊断和干预的重要性.
- 早期开始治疗对于延长恶性间皮瘤患者的生存至关重要.
- 化疗与抗血管药物 (如贝瓦齐祖马布) 的联合疗法提供了一个有前途的治疗策略.
相关概念视频
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Comparing the Survival Analysis of Two or More Groups
181
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
181
Kaplan-Meier Approach
136
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
136
Assumptions of Survival Analysis
126
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
126
Actuarial Approach
77
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
77
Introduction To Survival Analysis
231
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
231


